Results 171 to 179 of about 59,298 (179)

A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease. [PDF]

Acta Neuropathol
Bernhardt AM, Longen S, Trossbach SV, Rossi M, Weckbecker D, Schmidt F, Jäck A, Katzdobler S, Fietzek UM, Weidinger E, Palleis C, Ruf V, Baiardi S, Parchi P, Höglinger GU, Matthias T, Levin J, Giese A.   +17 more
europepmc   +1 more source

Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis. [PDF]

Brain Commun
Coles NP, Elsheikh S, Quesnel A, Butler L, Achadu O, Islam M, Kalesh K, Occhipinti A, Angione C, Marles-Wright J, Koss DJ, Thomas AJ, Outeiro TF, Filippou PS, Khundakar AA.   +14 more
europepmc   +1 more source

14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity. [PDF]

Neurobiol Dis
Wang B, Gannon M, Pattanayak R, Scholz K, Pair FS, Stone WJ, Ekkatine R, Liu Z, Yacoubian TA.   +8 more
europepmc   +1 more source

Age-dependent alpha-synuclein aggregation and Lewy body formation in Parkinson's disease. [PDF]

Neural Regen Res
Sung CC, Chung KKK.
europepmc   +1 more source